* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Hemoglobin A2: origin, evolution, and aftermath
Ridge (biology) wikipedia , lookup
Transposable element wikipedia , lookup
Public health genomics wikipedia , lookup
Genomic imprinting wikipedia , lookup
Epigenetics in learning and memory wikipedia , lookup
Epigenetics of neurodegenerative diseases wikipedia , lookup
X-inactivation wikipedia , lookup
Copy-number variation wikipedia , lookup
Genetic engineering wikipedia , lookup
Oncogenomics wikipedia , lookup
Epigenetics of human development wikipedia , lookup
History of genetic engineering wikipedia , lookup
Genome evolution wikipedia , lookup
Neuronal ceroid lipofuscinosis wikipedia , lookup
Saethre–Chotzen syndrome wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Gene desert wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
Genome (book) wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Gene nomenclature wikipedia , lookup
Gene therapy wikipedia , lookup
Gene expression programming wikipedia , lookup
Helitron (biology) wikipedia , lookup
Gene expression profiling wikipedia , lookup
Site-specific recombinase technology wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
Point mutation wikipedia , lookup
Microevolution wikipedia , lookup
From www.bloodjournal.org by guest on June 16, 2017. For personal use only. The Journal of The American SocieQ of Hematology BLOOD NOVEMBER 1, 1991 VOL 78, NO 9 REVIEW ARTICLE Hemoglobin A,: Origin, Evolution, and Aftermath By Martin H. Steinberg and Junius G. Adams 111 T H E MELANGE of hemoglobins present in the erythrocytes of humans includes hemoglobin A, (HbA,),’., a Its unique tetramer of a- and &globin chains (a26,). characteristics reside in the n~n-a-chain.~ HbA, is physiologically unimportant because it is normally less than 3% of the total Hb. The study of HbAz has provided insights into the evolution and phylogeny of globin genes and enhanced our understanding of gene expression and globin synthesis. HbA, has substantial clinical relevance. Its concentration fluctuates in the thalassemia syndromes and some acquired diseases, so that its measurement provides a useful diagnostic aid. This review will focus on the structure, function, and synthesis of the &-globin chain and HbA,, as well as the features of this Hb that give it clinical utility. CHARACTERISTICS OF THE &GLOBIN GENE The evolution of the &globin gene was initially very confusing, because HbA, was present in humans, apes, and New World monkeys, but not in Old World monkeys.34” This finding was seemingly at variance with the evolutionary data which indicated that humans and Old World monkeys diverged after the divergence from New World Monkeys. This conundrum was ultimately solved with the finding that &globin genes are indeed present in Old World monkeys, but have been inactivated by mutation.3842 After examination of the gene sequence of a number of primate species, the origin of the &globin gene was first thought to have occurred relatively recently (about 40 nlillion years However, studies of the globin genes of mice, rabbits, and other primates make it more likely that this divergence occurred before the mammalian radiation approximately 85 to 100 Mybp, at about the same time as the E- and y-globin genes diverged.M4nIt is clear from the comparisons of &globin genes among mammals that the &globin locus has not evolved as an independent lineage, but has evolved in concert with the p-globin gene. In each of the mammalian orders examined to date, the &globin locus has acquired characteristics of the P-globin locus through gene conversion (a nonreciprocal exchange of genetic material between the two linked homologous genes).” 44 4‘47 cu These gene conversions have most often occurred in the coding regions, rendering these regions useless in the quest for the primordial %globin gene. Thus, the evolutionary origin of the &globin gene has been performed using flanking and intervening sequence data (especially I V S I I ) . ~ ~ Gene conversion and the &globin gene. The nonallelic gene conversion events postulated to occur during the evolution of the &globin gene are thought to have been rare when compared with the gene conversion between the two y-globin loci.44However, Petes” has made an interesting observation concerning the structural variants of HbA,. Linkage relationships and chromosomal location of the &globin gene. It has long been known that the p- and &globin genes were closely linked. These initial linkage data were derived from the study of families in which both p- and &globin variants were ~egregating.~.“’ The location of the p-globin gene family on the short arm of chromosome 11 involved a variety of molecular techniques.”.” The linear arrangement of the @-globingene cluster was determined from data derived primarily from gene mapping and is shown in Fig 1.”’-*‘ These genes have also been completely sequenced.”-” The general form of the &gene is akin to all other globin genes with three coding regions (exons) and two intervening sequences (introns). Evolution of the &globin gene. Because of the large body of sequence data that is available from the globin genes as well as the proteins that they produce, this gene family has provided an excellent opportunity to examine its molecular evolution. The globin genes are all thought to have arisen from a common globinlike heme protein (Fig 2). The earliest duplication of this ancestral gene led to the divergence of myoglobin and the globins that comprise Hb and most likely occurred approximately 700 million years before From the Department of Medicine, University of Mississippi School present (Mybp).32 The next duplication gave rise to the ofMedicine, and VA Medical Center, Jackson, MS. divergence of the a-globin genes and occurred approxiSubmitted June 17, 1991; acceptedAugust 21, 1991. mately 450 Mybp.32The P-globin gene is thought to have Supported by Research Funds of the Department of VeteransAffairs. duplicated about 180 to 200 Mybp into an ancestral gene for Address reprint requests to Martin H. Steinbe%, MD, (151), VA E- and y-globin and an ancestral gene for 6- and P-gl~bin.’~ Medical Center, 1500 E Woodrow Wilson Dr, Jackson, MS 39216. Approximately 110 to 130 Mybp, the E / ? parent gene This is a US government work. There are no restrictions on its use. diverged to establish the E and y lineages. 0006-4971191 17809-0049$0.00/0 Blood, Vol78, No 9 (November 1). 1991: pp 2165-2177 2165 From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2166 STEINBERG AND ADAMS Chromosome 11 H 5kb Fig 1. The arrangement of the plike globin gene cluster. - Two of the then-described 10 &-globinvariants could have arisen by gene conversion. The &globin variants HbA, Flatbush (622 ala + glu) and HbA, Coburg (6116 arg his) both contain a P-globin amino acid in 1of the 10 amino acid residues where these two globins differ. The occurrence of these variants is much greater than would be expected for random mutation. Therefore, Petes suggested that these two variants could represent gene conversion events. Another variant that was found subsequent to Petes’ hypothesis, Hb Parchman (622 ala + glu, 50 ser thr), could also be due to gene conversion rather than to a double crossover as proposed by the investigators.s2This hypothesis is easily testable in the variant HbA, Coburg, because a gene conversion event would result in a codon 116 change of CGC to CAT, while a point mutation would result in a CGC to CAC change.’’ Synthesis of the &globin chain. Clearly gene conversion has maintained strong sequence homology between the human P- and &globin genes. This homology is especially striking in the coding regions where there are 10 amino acid differences and 31 nucleotide differences. However, the quantitative expression of these two genes is strikingly different. HbA makes up more than 95% of the adult hemolysate, while HbA, comprises only 2% to 3%. The molecular stability of these two molecules appears to be almost identical, making it highly unlikely that difference in posttranslational survival of the two molecules accounts for the low proportion of HbA,. In studies where reticulocytes were incubated with radioactive precursor amino acids, it became apparent that the &globin chain is synthesized at a reduced rate in the bone marrow and not at all in reticulocyte~.’~.’~ These experiments were extended by fractionating bone marrow erythroblasts into fractions of different levels P My b.p. I A -190 AA e Y 6 p -130 c* 85 (Mammalianradiation) Fig 2. The evolutionary history of the &-globingene. of maturity. These experiments showed that there was a progressive decrease in &-globin synthesis in relation to P-globin in increasingly mature cells. A relative instability of 8-globin mRNA was proposed as a mechanism for the premature decrease in &globin synthesis? Using highly selective probes for P- and &globin mRNA, it was found that the half-life of &globin mRNA was less than one third that of P-globin mRNA, supporting this hypothesis.” Despite the strong evidence that 6-globin synthesis decreases during the maturation of erythroid precursors, this decrease does not account for the great discrepancy between P- and &globin synthesis. In normal bone marrow cells, the synthesis of &globin chains is less than 2% of total non-a-globin synthesis. In addition, even in the youngest fraction of bone marrow erythroid cells examined, the 6:P-globin synthesis ratio did not exceed the usual HbA2: HbA ratio found in the peripheral blood. Furthermore, the translation rates of the two globins were the ~ a m e . ~ ‘ These findings strongly suggested that the rate of transcription of S-globin gene must be less than that of the P-globin gene. When the in vitro transcription of non-aglobin genes was compared, it was found that P-, E-, and y-globin genes are transcribed with equal efficiencies, but that the transcription of the 6-globin gene is far less efficient.” Humphries et a P compared the expression of a-, P-, and &globin genes in monkey kidney cells. Under conditions that promoted optimal transcription of each globin gene in this system, &globin gene transcription was found to be 50 times less efficient than that of the P-globin gene. This transcriptional deficiency of the &globin gene approximates the synthesis of &globin in normal erythroid cells. Humphries et al also made hybrid constructs of the 6and P-globin genes. When the 5‘ end of the &globin gene was replaced by the homologous portion of the P-globin gene, transcription of this hybrid gene was equal to that of the normal P-globin gene. However, when the 5’ portion of the p-globin gene was replaced by the homologous portion of the &globin gene, the transcription of the hybrid gene was like that of the &globin gene. These findings suggested that sequences in the 8-globin gene promoter were responsible for the decreased transcription of this gene. One of the most striking differences between the P- and &globin genes is that the usually conserved CCAAT box is the 5’ promoter region is CCAAC in the &globin gene and is the expected CCAAT in the p-globin gene. Because the CCAAT box is required for normal transcription of the rabbit P-globin gene? this difference is thought to account for most of the differences in the synthesis of P- and S-globin synthesis. It has been shown that IVS-I1 of the &globin gene also acts to reduce its synthesis by mechanisms that are unclear now.M’ HbA, is synthesized in all erythroid progenitors and therefore its distribution in the blood is pancellular.61This contrasts with the expression of the y-globin gene in adults, where only a minor fraction of erythrocytes (F cells) contains HbF. This difference in the expression of these two minor Hbs found in adults may result from the restriction of y-gene expression to a very few erythroid precursors. The special mechanisms that govern switching from fetal to From www.bloodjournal.org by guest on June 16, 2017. For personal use only. HEMOGLOBIN A, 2167 Lepore globin genes produces a chromosome with a 8-PS-P adult Hbs within the mammalian @-globin gene cluster configuration. Two of these “anti-Lepore” variants have inactivates the y-globin genes as 6- and P-gene transcripbeen found, Hb Miyada” and Hb P N i l o t i ~ . ~Because ~.~~ tion is activated.62 these individuals have a normal P-globin gene, they do not Function of HbA, and the &globin chain. HbA, has exhibit a thalassemic phenotype. The anti-Lepore globin functional properties that are nearly identical to those of gene has the P-globin gene promoter, so synthesis of these HbA. It has similar oxygen affinity, Bohr effect, and globins would be expected to be near that of the P-globin ~ooperativity.6~,~~ Its response to 2,3 bisphosphoglycerate is gene. In Hb P Nilotic heterozygotes, the variant Hb was also similar to that of HbA.65The thermal stability is greater This than that of HbA.& HbA, inhibits polymerization of HbS.67 found to comprise 21% to 28% of the hem~lysate.~~.~’ proportion closely approximates that expected if the P The residues 622 (Ala) and 687 (Gln) appear to be the Nilotic globin chain was synthesized at nearly the same rate important inhibitory sites. In instances where the HbA, is as the normal P-globin chain. It has been shown that the exceptionally high, and in the presence of elevated HbF synthesis of Hb P Nilotic decreases in reticulocytes as levels, the combination of these two Hbs may modulate the compared with bone marrow cells,77but this decrease in phenotype of HbS-Po-thalassemia.68The positive charge of synthesis is not a major determinant of the total synthesis of HbA, may endow it with properties similar to other posithis globin because it appears to accumulate in the expected tively charged Hbs, such as HbC, relative to its interaction amounts in red blood cell (RBC) precursors. The synthesis with the erythrocyte HbA, has a higher affinity of the PG-globin chain of Hb Miyada is apparently synthefor erythrocyte membrane band 3 than does HbA.70While sized somewhat less efficiently than Hb P Nilotic, compristhe interaction of HbC with the membrane is believed to ing only 17% of the hemolysate in heterozygous individudetermine the pathophysiologic properties of HbAC and a l ~The . ~ synthesis ~ of this abnormal globin was also found HbCC cells,71the concentrations of HbA, make it doubtful to be greatly decreased in reticulocytes when compared that it can meaningfully affect cation transport and mean with bone marrow cells.78 corpuscular Hb concentration. The non-a-globin chain of Hb Parchman is also informaHybrids of the p and &globingenes. The Lepore Hbs are tive in this regard. If Hb Parchman arose a double crossover the products of SP hybrid globin genes and have provided as initially suggested, it should contain the &globin gene insight into the mechanisms of decreased &globin synthepromoter, IVS-I from the p-globin gene, and IVS-I1 from sis. In 1958, Gerald and Diamond7* showed that the inthe &globin gene. The non-cu-globin chain of Hb Parchman dividuals who carried this variant exhibited hematologic is synthesized at the same rate as the normal &globin chain, manifestations identical to P-thalassemia, but had an elecsupporting the suggestion of Kosche et @ aI’ that the detrophoretically slow-moving Hb that comprised 10% to creased synthesis of the &globin chain is due to the 15% of the total hemolysate. Subsequently, B a g l i ~ n i ~ ~ presence of the CCAAC promoter and the &globin gene showed that the non-cu-globin chain of Hb Lepore had IVS-11. &globin sequences at its amino terminus and P-globin &Globin variants. The known structural variants of the sequences at its carboxyl terminus. The Lepore Hbs most &globin gene are depicted in Table 1. Although these likely arose from a nonhomologous crossing over event in variants may be unstable or have elevated oxygen affinity, which the P-globin gene from one chromosome mispaired they are not associated with a clinically significant phenowith the &globin gene of the other chromosome during type because, as mentioned previously, HbAz has no detectsynapsis. The result of this recombination is the deletion of able effect on the oxygen transport of the RBC due to its a segment of DNA approximately 7 kb in length from a low proportion. Because HbA, variants have no effect on point within the transcribed portion of the &globin gene to phenotype, the number of structural variants of the &globin a corresponding point in the P-globin gene. Therefore, the Lepore chromosome does not have a normal 6- or @-globin gene is far less than that of the a-or P-globin gene. gene. CLINICAL FEATURES OF HBA, Current concepts of how the Lepore SP fusion gene variants produce the phenotype of thalassemia are that the Measurement of HbA,. The &chain of HbA, contains &globin gene sequences located at the 5’ portion of these two additional positive charges compared with the P-chain fusion genes result in their characteristically reduced rate of HbA. This facilitates its separation by electrophoretic and chromatographic methods that rely on charge differof ~ynthesis.’~The major difference in this region, as mentioned previously, is that in the &globin gene, the ences to resolve proteins from one another. Hb electroCCAAT box promoter sequence is CCAAC. Another phoresis on starch or polyacrylamide gels or cellulose puzzling feature of the Lepore globin chain was that is was acetate membranes affords wide separation of HbA, from HbA and HbF and a means to quantify accurately this synthesized at a higher rate than the &globin chain of minor Hb ~ o m p o n e n t . ~ Acid HbA,. This increased synthesis of the hybrid globin is most ~ . ’ ~ agar gel electrophoresis likely due to the presence of the second intervening does not resolve HbA, from HbA. The ease of working with sequence of the P-globin gene.@The rare homozygous forms cellulose acetate membranes, their commercial availability of Hb Lepore, as well as combination of Hb Jipore with other and reasonable cost, makes this the current electrophoretic P-thalassemia genes, are usually expressed clinically as modermethod of The low level of HbA, in erythrocytes, ately severe forms of thalassemia major.74 and the narrow range separating normal from abnormal, The reciprocal product of the crossover that produces the causes methods of measurement that are facile from the From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2168 STEINBERG AND ADAMS Table 1. Structural Variants of the &Globin Gene Mutation GIG + CCG CAT -+ CGT A A I + nqc! or AAG GGC + CGC CIG + GAG GCA -+ G F - Amino Acid Residue No. Abnormality 1 (NA1) 2 (NA2) Val + Ala His + Arg A, Niigata A, Sphakia 12 (As) 16(A13) 20 (82) 22 (84) Asn + Lys Gly+Arg Val -+ Glu Ala + Glu A, NYU A; A2Roosevelt A, Flatbush Hb Name 24 (B6) 25 (87) 43 (CD2) 47 (CD6) 51 (D2) 69 (E13) Gly + Asp Gly + Asp Glu + Lys Asp + Val Pro + Arg Gly + Arg A, A, A, A, A, A, Victoria Yokoshima Melbourne Parkville Adria Indonesia GAG -+ GIG 90 (F6) 98 (FG5) 99 (Gl) 116 (G18) 116 (G18) 121 (GH4) 125 (H3) 136 (H14) 142 (H20) Glu -+ Val Val + Met Asp + Asn Arg -+ His Arg + Cys Glu -+Val Gln + Glu Gly -+ Asp Ala + Asp A, A, A, A, A, A, A, A, A, Honai Wrens’ Canadat Coburg Corfu ManzanaresI Zagreb Babinga Fitzroy -+ CGC + CAC or CATS + JGC G&I + G I A CAA + GAA GGT + GAT GCT + GAT -CGC % Variant Reference XR XR - 184 185 Indian Eastern European Black American Iraqi Black American Babinga pygmies Iraqi Japanese Italian ? Italian Malayan Sumatran Japanese Black American East Indian Italian Greek Spanish Yugoslavian Babinga pygmies Greek q = .004 R q = .009 XR 1.o 1.o 1.o 186 6.7.10 187 188 1.3 1.6 1.4 189 190 191 192 193 194,195 0.8 0.2 1.8 1.4 0.5-1.5 0.4 1.1 1.o 1.4 196 197 198 199 204 200 20 1 202 203 Population GGT -+ GAT GGT + GAT GAG +@ -G GAT + G F CCT -+ CGT GGT + CGT GTG ATG GAT + &IT Frequency Japanese Cretan Canadian R q = ,024 XR XR XR XR XR q = .001 q = .024 XR XR XR XR R XR XR q = ,0007 XR - 44% of HbA, 1.2 - Abbreviations: R, rare; XR, extremely rare. *Unstable. tHigh oxygen affinity. *See text for details concerning possible gene conversion. standpoint of the clinical laboratory, such as densitometric tracings of electropherograms, to be i n a c c ~ r a t e . ~For ~-~ acceptable accuracy, the HbA, fraction must be eluted and measured spectrophotometrically.84Refrigeration and freezing may reduce the HbAz percentage in stored hemolysates.” The differential elution of HbA, in minicolumns is reliable, rapid, and inexpensive.’”” Both electrophoresis and conventional methods of column chromatography are incapable of separating HbAz from Hb variants that contain similar charge differences. Unfortunately, the very common HbC and HbE are in this group of positively charged Hbs. In the company of abnormal globins that contain only a single additional positive charge, like the sickle p-chain, the HbAz level has been reported to be higher than normal.%However, good laboratory technique and the choice of appropriate separative methods can circumvent this complication and permit the use of electrophoresis and chromatography to measure HbA, in the presence of HbS.80,95,97,98 High performance liquid chromatography (HPLC) can separate HbA, from other Hb types as well as discriminate the 8-globin chain of HbA, from a,p, and y-globin chains. Cation exchange columns afford excellent resolution of HbA, from HbS and HbC,99-1”1 but the time and expense of this method detract from its clinical use. The quantification of non-cu-globin chains using a C, column (Vydac, Hisperia, CA) provides a useful surrogate for the measurement of intact Hbs and contributes an effective way of assessing HbA, in the presence of HbC or HbE.’02-1” HbA, may be measured i m m u n o l o g i ~ a l l y . This ~ ~ ~ ~tech’~~ nique has the virtue of specificity. The levels obtained correlate well with the more traditional methods of measurement. To date, this procedure has not enjoyed wide clinical application. HbA, in health and disease. There is little &-chain synthesis in utero and the accumulation of HbAz does not become easily measurable until late in gestation. The HbA, level in normal newborns is 0.27% f 0.02%.” The amounts of HbAz vary with gestational age; they are lowest in the least mature infants.”’ HbA, levels do not increase synchronously with HbA, but lag behind; the HbA/HbA, ratio is about 100 at 32 weeks of gestation and 75 at 45 weeks.”’ The “adult” HbA/HbA, ratio of about 40:l is not reached until at least 6 months of age. This sluggish response of HbA, during maturation may reduce its value for the diagnosis of P-thalassemia in young infants.”’ The stable, “adult” level of HbA, is 2.5% to 3.5%. In the presence of an a-globin variant, such as HbGPh“ade’ph’a , the variant a-chain combines with the 8-chain to form an Hb tetramer with the structure, aVar’an128T11’ This tetramer, often called HbG,, usually comprises less than one half the total amount of HbA,. The HbA, “variant,” HbG,, is more positively charged than HbA, because of the positive charge of the‘a chain, and is easily separated from HbA,. Extra HbA, bands are a valuable clue to the presence of variant a-globin chains, although, depending on the charge of the a-variant, they may or may not separate from the major Hb bands.”’ Glycosylated forms of HbA,, analogous to the minor From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2169 HEMOGLOBIN A, components of HbA, are present and can be quantified by HPLC and isoelectric f o c ~ s i n g . " ~As ~ " ~with HbA,,, these glycohemoglobins are elevated in poorly controlled diabetics. Low HbA,. The causes of reduced levels of HbA, are shown in Table 2. Other than the age-related decrement from "normal" found in infants and very young children, low HbA, values are in most instances the result of either reduced synthesis of the &globin chain (thalassemia), or posttranslational modifications in the assembly of the HbA, tetramer (Table 2). Reduced HbA, tetramer assembly can result from either acquired or genetic disorders. In either case, the proximate cause is the same; a reduction in the synthesis of a-globin chains. Posttranslational causes of reduced HbA,. Hb tetramer assembly follows rapidly on the formation of dimers consisting of a- and non-a-globin chain^.''^^"^ Dimer formation, in turn, is dependent on the charge of the non-a-chain. Normal a- and P-monomers have nearly equivalent positive and negative charges, respectively, and are united by electrostatic attraction. The &-chain is more positively charged than the p-chain (or y-chain). Under normal conditions when there is a-chain sufficiency or slight excess, HbA is formed in priority to HbA,, because a p dimers form in preference to a8 dimers. When the supply of a-globin chain is limited, the effect of charge is exaggerated, as the p-chain (and y-chain) compete more effectively than the &chain, for the limited quantity of a-globin." Acquired conditions causing low HbA,. A number of acquired conditions are capable of reducing a-globin synthesis relative to that of non-a-chains. Most seem to have their effect through the common mechanism of absolute or functional iron deficiency. In the absence of sufficient iron, a repressor of initiation of protein synthesis is formed."' This may preferentially affect a-, rather than non-a-globin chain initiation, resulting in a relative deficiency of a-chains. Patients with iron deficiency anemia have reduced levels of HbA,. This is most apparent in individuals with the most severe iron deficiency."'-'22 Individuals with anemia, microcytosis, and low levels of HbA, on the basis of iron deficiency might be mistaken for carriers of one of the more severe forms of a-thalassemia. When iron deficiency and Table 2. Causes of Reduced Levels of HbA, Reduced &Globin Synthesis Neonatal period 8-Thalassemias 8p and yap-Thalassemias Lepore Hbs &Globin chain variants Reduced HbA, Tetramer Assembly Genetic a-Thalassemia Acquired Iron deficiency Lead poisoning Sideroblastic anemia Myeloproliferative disorders p-thalassemia coexist, the HbA, level has been reported to decrease,"' although it may remain within the range expected for thalassemia heterozygotes.l' Iron deficiency may not affect the HbA, in all patients with p-thalassemia. We recently studied two patients heterozygous for the -88 C + T p'-thalassemia who also had iron deficiency anemia. Their HbA, levels were appropriately elevated while they were iron deficient and did not change during iron repletion. The iron utilization defect associated with sideroblastic anemias may also reduce HbA, level^."^ There may be profound effects on a-globin synthesis in certain myeloproliferative disorders. The expression of all a-globin genes is affected and the phenotype can mimic the genetically determined HbH disease. While these instances are uncommon, they can be associated with low HbA, values. The HbA, level in acute myeloid leukemias (AML) is lower than in acute lymphocytic leukemias.IzsThis, and other hematologic differences between these groups, suggests that the AML clone involves the erythroid lineage. In juvenile chronic granulocytic leukemia a pattern very similar to fetal erythropoiesis may develop. Fetal Hb levels may soar, accompanied by low HbA, values, recapitulating normal neonatal findings and the reciprocity of y- and &globin gene expression.126-128 Erythroleukemia has also been associated with very low levels of HbA, in the absence of HbH.'29,'M Conceptually, these acquired "a-thalassemias" bridge the difference between the reduced HbA, secondary to acquired disease and low HbA, associated with genetic abnormalities of a-globin synthesis. Genetic conditions associated with low HbA, a-Thalassemia is extraordinarily common in certain populations. The deficit in a-chain synthesis ranges from trivial to extreme and the level of HbA, varies commensurately with the deficit in a-globin synthesis.'" With the mildest types of a-thalassemia, HbA, values in individuals may be indistinguishable from normal. When a-globin production is impaired significantly, the reduction in HbA, is dramatic. In 21 patients with HbH disease, the HbA, ranged from 0.5 to 1.8% and averaged 0.8%.13, Homotetramers of &chains have been reported in a-thalassemia hydrops fetalis. The Sthalassemias. Thalassemia-inducing mutations may affect the &globin gene. Uncomplicated &thalassemia has no clinical repercussions. In &+-thalassemia,both heterozygotes and homozygotes have reduced HbA, levels. When the &gene is totally inactivated (F-thalassemia), the heterozygote has half normal HbA, levels, while HbA, is absent in the homozyg~te."~ When &gene expression is abolished as a result of large DNA deletions that remove the p-, and at times the y-globin genes, as well as the &gene, the resulting phenotype is a consequence of impaired p- or y-gene expression. Heterozygotes for GP-thalassemia and gene deletion hereditary persistence of fetal Hb (HPFH), have half-normal HbA, levels; homozygotes have no HbA,.'I9 With Lepore Hbs there is a 50% reduction of HbA, level in heterozygotes and no HbA, in homozygotes. While the percentage of HbA, may be low when &globin gene expression is abolished, the absolute level, expressed as picograms of HbA, per cell, is slightly elevated. This reflects increased synthesis From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2170 STEINBERG AND ADAMS of HbA,from the chromosome in trans to the gene deletion (see below). Early descriptions of &thalassemia were based on hematologic and family studies. In the context of our present ability to define the thalassemias at the molecular level, some of these reports are unreliable. The mutations described in the 6-thalassemias are shown in Table 3. There have been a few surprises among these mutations and they resemble the defects that have been found to cause other thalassemias like frameshift mutations, splicing defects, gene deletions, and possible unstable H ~ s ’ ” . ”(~Trifillis P, Ioannou P, Schwartz E, Surrey S: Identification of four novel &globin gene mutations in Greek Cypriots using PCR and automated fluorescence-based DNA sequence analysis. Blood [in press]). Several of these &thalassemiacausing mutations are also &globin structural variants. These variants are similar to the thalassemic hemoglobinopathies caused by some a- and P-globin gene mutants. Reflecting the relative rarity of gene deletion with the p-like globin gene cluster, there is but a single reported example of gene deletion causing “pure” &thalassemia. A 7.2-kb deletion removed most of the &gene and stopped just 3’ to the +P-gene. While the initial molecular characterization of this deletion suggested that it inactivates the P-gene, subsequent studies make it likely that a p+thalassemia mutation was responsible for the reduced expression of the P-gene in cis to this deletion.’3s3139 The 6-thalassemias have been reported most often in Japanese, Italian, and Greek populations. Whether this represents their true distributions is not known, as extensive surveys for these barely detectable conditions have yet to be reported. In Italians, and potentially in other ethnic groups where P-thalassemia is common, the coexistence of &-thalassemiamay cause the HbA, to be normal in the presence of P-thalassemia.I3l Interactions between a-thalassemia and p-thaIassemiamay also result in normal HbA, vah~es.’~’ These “normal HbA, p-thalassemias” may escape detection if diagnosis depends on the measurement of HbA, levels alone. Table 3. Molecular Causes of the 8-Thalassemias 8”-Thalassemia Codon 91 frameshift, insertion of A; premature stop at position 94135 T + C, IVS-1, position 1. Abolishes splicing’” T + C, position -77. ?Transcriptional defect’= T + C, position 2 of condon 141 (leu-pro). ? Unstable Hb* A + G, IVS-2 3’ splice site. Normal splicing disrupted* AAG + AG, codon 59. Frameshift; premature stop at codon ~~137.13111 7.2-kb deletion, extending from 3’ 6p through IVS-2 of the 8-gene.”.lm 8’-Thalassemia G + T, position 1 of codon 27 (ala-ser). 7 Cryptic splice site activation’” C + T, position 1 of codon 116 (arg+cys).* ‘Trifillis P, loannou P, Schwartz E, Surrey S: Identification of four novel &-globin gene mutations in Greek Cypriots using PCR and automated fluorescence-based DNA sequence analysis. Blood (in press). A priori, mutation in the &globin gene should be as frequent as that in the P-globin gene. Yet, far fewer 6-thalassemia-causing mutations and &globin variants have been described. The explanations for this anomaly are probably twofold. First, the lack of clinical or hematologic abnormalities associated with &thalassemia (or &chain hemoglobinopathies) makes its detection difficult; second, the inconsequential hematologic change of &thalassemia provides an insufficient basis for natural selection to protect the carrier from Falcipamm malaria. HbA, levels of approximately half normal are present in individuals heterozygous for &-chain v a r i a n t ~ . ’ ~In~ ’this ~~ instance, the level of the HbA, variant is equivalent to HbA,, and the sum of both minor Hbs is equal to the normal HbA, level. Homozygotes for HbA,variants have no normal HbA,. High HbA,. High HbA, levels are a result of P-thalassemia in almost all instances.’ With few exceptions, an elevated level of HbA,,in the presence of microcytic erythrocytes, equates to the diagnosis of heterozygous P-thalassemia. Borderline levels of HbA, are not common when modern methods of measurement are used. In these instances, the absence of microcytosis makes the diagnosis of heterozygous P-thalassemia unlikely, although with some of the “mild” P-thalassemia mutations the erythrocytes may be However, P-thalassemia may be present with normal levels of HbA,. One important caveat is the case where the coexistence of &thalassemia or a-thalassemia conspires to reduce the HbA, levels toward normal. The HbA, level may be higher in heterozygous v-thalassemia than p+-thalassemia.I3’This is likely to be a result of the greater impairment of p-chain synthesis in v-thalassemia. The overlap in values precludes any diagnostic utility of this observation. Only a minority of the point mutations causing P-thalassemia are not associated with a raised HbA, level. It appears that p-thalassemia mutations that lead to only mild impairment of P-globin synthesis are accompanied by more modest elevations of HbA, than the more severe p-thalassemia-causing mutation^.'^'^' This may be a result of posttranslational dimer assembly, where a relatively nominal suppression of P-chain synthesis and minor excess of a-globin chains leads to less ab-dimer formation. An exception may occur when the mutation affects the P-gene promoter. Codrington et all” propose that point mutations in the P-globin gene promoter may alter its binding of transcription factors and augment &gene transcription in cis. In one patient with the -88 C + T p’-thalassemia and HbA;in trans, the total of both HbA, types was about 7%. They also reported an HbAzlevel of 5.4% f 0.4% (4.5% to 6.6%) in 10 heterozygotes with this same mutation. We found an average HbA, of 4.87% (4.1% to 5.2%) in six heterozygotes with this mutation from a single family (unpublished data, July 1991).There appears at this time to be insufficient data to precisely define the effects of p-gene promoter point mutations on HbA, synthesis. HbA, levels in homozygous p-thalassemia are variable and of little diagnostic value. This is a result of the striking increases of HbF that typify the severe P-thalassemias. Transcription of the &globin gene appears to vary in a From www.bloodjournal.org by guest on June 16, 2017. For personal use only. HEMOGLOBIN A, reciprocal fashion with that of the y-globin gene. This reciprocity is evident as HbF levels decrease rapidly during the last trimester of gestation and is also observed in the P-thalassemia syndromes.'" In homozygous P-thalassemia, cells with the highest HbF levels have the lowest HbA, concentrations.Ia The relationship between HbA, and HbF was strikingly illustrated in a patient with p-thalassemia trait and the Swiss type HPFH receiving chemotherapy. The HbF level increased dramatically, from 4.5% to 26%, accompanied by a decrease in HbA, from 4.5% to 2.4%.'49 The cause of increased HbA, in heterozygous @-thalassemia appears to reside at both the transcriptional and posttranslational level of Hb There is an increase in both the percentage and absolute amount of HbA, present, with the former about twice as great as the latter. Reduced production of P-globin, with a relative excess of a-globin chains, favors the formation of a 8 dimers and the assembly of HbA, tetramers. If part of the cause of elevated HbAz was due to posttranslation perturbations, the product of each &-globin gene should contribute equally to this increase; ie, the effect should be present both in cis and in trans to the @-thalassemia gene. This has been shown directly in the study of families where a structural variant of the &globin chain segregates independently from the P-thalassemia-causing m u t a t i ~ n . ' ~ ~Increased ~ ~ ~ . ' ~ ' 6-gene transcription, as a result of a p-thalassemia-causing mutation, might be expected to occur only in cis. The mechanism for the "compensatory" increase in &globin synthesis is not totally clear but may result from a "competition" among the p-globin-like gene promoters for transcription factors.Iu Exceptional& high HbA,. The mean level of HbA, in 879 carriers of P-thalassemia of diverse ethnic backgrounds was 5.08% f 0.39%.15' The highest observed value was 6.8%. In 184 black patients with P-thalassemia trait the mean HbA, level was 4.97% 2 1.07%.15' Some individuals with P-thalassemia trait have HbA, concentrations that are significantlyhigher than these mean levels. The exceptionally high HbA, levels are usually the result of a unique and informative class of small deletions of DNA that usually begin within the P-globin gene and extend 5', removing the gene promoters. A summary of the mutations so far described that are associated with high HbA, are shown in Fig 3. These deletions may have direct repeats, partial homologies, purine-rich regions, AT-rich sequence, topoisomerase I1 recognition sites, and homologies to donor splice sequences in proximity to their 5' and 3' ends. These have been postulated to lead to nonhomologous recombinations by several mechanism^."^ In contrast to the very high H b 4 present with these 5' deletions, the 600-bp deletion in the 3' portion of the P-globin gene, found in Asian Indians with Po-thalassemia, is associated with typical HbA, levels.154A 3.4-kb deletion has its 5' terminus between nucleotides -810 and -128 while the 3' breakpoint is located between the Avu I1 and Xmn I sites that lay 3' to the P-gene. This deletion removes both the P-gene promoters and the 3' enhancer. The HbA, level in the single heterozygote examined was 6.7%. Perhaps the loss of the 3' enhancer element modulates the increase of HbA, expected from the removal of the proximal promot- 2171 Fig 3. Positions of those fbglobin gene deletions, relative to the p-globin mRNA capping site, that have been associated with unusually high levels of Hbh. The -3,400-bp deletion does not yet have precisely defined 5' or 3' termini, and the 5' region of uncertainty is indicated by the wavy line. This deletion appears to be characterized by an HbA, level that is intermediate between the typical p-thalassemias and those caused by the 5' deletions that have breakpoints within the p-gene. The references for each deletion are: 532bp."; 1,393 bp."; 290 bp."'; 3,400 bp."; 4,237 bp,1'2; 12,622 bp.'". Modified with permission." e r ~ .A' ~newly ~ described deletion of 44 bp begins in codon 24 or between codons 24 and 25 and extends 26 or 27 bases into IVS I.153As the P-gene promoter is left intact, one would predict that the level of HbAz would be similar to that seen in the bulk of P-thalassemias. Unfortunately, there is no information regarding HbAz levels in heterozygotes for this deletion. The removal of the P-globin gene promoter sequences by the 5' deletion may increase the likelihood that transcription factors, such as GATA-1,lS6bind the remaining 6- and y-gene promoters, enhancing the transcription of these genes. Alternatively, deletion-induced disruption of higherorder DNA or chromatin structure may make y- and &promoters more accessible to the locus control region (LCR). The LCR, a series of DNA'ase hypersensitive sites that lie about 30 kb 5' to the €-globin gene, plays a major role in governing transcription of the @-likegenes. The LCR appears to interact with the P-like gene promoters in a competitive f a ~ h i o although n ~ ~ ~other ~ ~ mechanisms ~ ~ ~ ~ ~may be po~sib1e.I~~ The absence of a functional P-promoter might permit the LCR to interact with the &gene in cis, enhancing its expression. These proposed explanations for increased &gene expression in these interesting P-thalassemias due to 5' deletions are not mutually exclusive. Point mutations in the P-globin gene promoter may be associated with higher HbA, values than similar mutations elsewhere in the P-gene. Perhaps, in a fashion analogous to the situation where the P-gene promoters are deleted, these mutations alter the binding of transcription factors and favor expression of the &globin gene. In deletion HPFH and SP-thalassemia, DNA rearrangements that reposition the 3I-P-gene enhancer that binds GATA-1, in closer proximity to the y-globin loci, have been postulated to influence y-gene e x p r e s s i ~ n . ' ~The ~ . ' ~5' P-gene deletions must have minor, if any, effect on the actions of this enhancer. This class of P-globin gene deletions also have the potential to confound the prenatal diagnosis of sickle hemoglobinopathies as they remove DNA that would hybridize with most allele-specific probes for the Psgene. Patients From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2172 STEINBERG AND ADAMS heterozygous for both HbS and a 5' deletion Po-thalassemia decrease in HbA, and an increase in mean corpuscular volume (MCV).168,'69 The HbA, levels in untreated, nonanewould then appear to be homozygous for the psgene. The HbA, levels in heterozygotes for these 5' P-gene mic, hypothyroidism, cluster toward the low end of nordeletion thalassemias have been reported to range from mal.169In hyperthyroidism, the combination of high HbA, about 7% to 12%. We are unaware of the description of and low MCV can be confused with P-thalassemia. instances of bona fide HbA, levels that exceed the top of Megaloblastic anemias have been associated with HbA, concentrations that exceed normal level^.^"^^^^ The most this range. Laboratory reports of HbA, values more than 15% or 20% are apt to be spurious or represent instances of severely anemic patients have the highest HbA, values."' HbC or HbE heterozygosity complicated by a-thalassemia. However, the incidence of this finding seems low, the Another theoretical possibility for exceptionally high level magnitude of the increase above normal is slight, and, in one study, the means of the HbA, levels in the normal and of HbA, is the presence of a Miyada-type Hb, or PG-fusion gene, where the point of crossing over leads to a globin megaloblastic anemia groups were ~imi1ar.I~'Perhaps the high HbA, of megaloblastic anemia is a result of more Hb chain structurally identical ot When this possibilsynthesis occurring in less mature erythroid precursor^.^' ity was directly evaluated by restriction endonuclease mapping, it was not d 0 c ~ m e n t e d . lRecent ~~ follow-up of this The HbA, levels appear to be increased in some instances of unstable H ~ s . ' ~ This ' , ' ~ is~ likely to be a postcase, after the reports of the effects of 5' P-gene deletions on HbA,, and using more sensitive methods of analysis, translational event where the unstable P-chain has difficulty showed the presence of the 1.4-kb 5' P-gene deletion.162 forming @-dimers. Malaria infestation and elevated HbA, levels have been Miscellaneous causes of high HbA,. Some methods of linked in some report^"^-'^^ but not other^.'^^,'^^ The best measurement have reported elevated levels of HbA, in controlled study casts doubt on such an ass~ciation.'~~ The sickle cell trait (HbAS) and sickle cell anemia (HbSS)?6 association of hereditary spherocytosis and very high HbA, Patients with H b S S - a - t h a l a ~ s e m i a ' ~ ~and . ' ~ ~HbS-POlevels has also not been proven.'78 t h a l a s ~ e m i a ~ have ~ ~ ' ~ 'high HbA, concentrations. In the former group of patients, the &chain competes more CONCLUSION effectively than the ps-chain for the limited quantities of Genetic abnormalities that affect solely the &globin gene a-chain. Mos~,~',"but not all,'66,167 methods of measuring have no clinical significance for their carriers. But, tracing HbA, in HbAS give results that are identical to or nearly the origin and evolution of this locus has contributed to our indistinguishable from normal. knowledge of the plasticity that is inherent within the HbA, levels appear to be consistently elevated in hyperthyroidism, albeit not as markedly as in P - t h a l a s ~ e m i a . ' ~ ~P-globin-like . ~ ~ ~ ~ ~ ~ gene cluster. The variation in the level of HbA, that accompanies the thalassemia syndromes and Both the percentage and absolute amount of HbA, are certain acquired diseases often provides very useful diagnosincreased, suggesting increased synthesis of the &globin tic information. Thus, the vestigial 6-locus has achieved chain, and an effect of thyroid hormone on &gene transcripclinical relevance that far eclipses its physiologic influence. tion."' Euthyroidism, after treatment, is accompanied by a - REFERENCES 1. Kunkle HG, Wallenius G: New hemoglobin in normal human blood. Science 122:288,1955 2. Kunkle HG, Ceppellini R, Muller-Eberhard U, Wolf J: Observations on the minor basic hemoglobin component in the blood of normal individuals and patients with thalassemia. J Clin Invest 36:1615,1957 3. Atwater J, Huehns ER, Shooter EM: Haemoglobin I,, a further variant of haemoglobin A,. J Mol Biol3:707,1961 4. Horton BF, Huisman THJ: Linkage of the p-chain and &chain structural genes of human hemoglobins. Am J Hum Genet 15:394,1963 5. Boyer SH, Rucknagel DL, Weatherall DJ, Watson-Williams EJ: Further evidence for linkage between the p and 6 loci governing human hemoglobin and the population dynamics of linked genes. Am J Hum Genet 15:438,1963 6. Stamatoyannopoulos, G, Weitkamp LR, Kotsakis P, Akrivakis A The linkage relationships of the f3 and 6 hemoglobins genes. Hemoglobin 1:561,1977 7. Ceppellini R: L'emoglobina normale lenta A,. Acta Genet Med Gemellol8:47, 1959 8. Pearson HA, Moore MM: Human hemoglobin gene linkage: Report of a family with hemoglobin B,, hemoglobin S, and p thalassemia, including a probable crossover between thalassemia and 6 loci. Am J Hum Genet 17:125,1965 9. Mishou MK, Nance WE: Further evidence for the close linkage of the Hb p and Hb 6 loci in man. J Med Genet 6:190,1969 10. Weatherall DJ, Clegg JB, Milner PF, Marsh GW, Bolton FG, Serjeant GR: Linkage relationships between p- and 6-structural loci and African forms of p thalassaemia. J Med Genet 13:20, 1976 11. Deisseroth A, Velez R, Nienhuis AW: Hemoglobin synthesis in somatic cell hybrids: Independent segregation of the human aand p-globin genes. Science 191:1262,1976 12. Deisseroth A, Nienhuis A, Lawrence J, Giles R, Tuner P, Ruddle FH: Chromosomal location of human p globin gene on human chromosome 11 in somatic cell hybrids. Proc Natl Acad Sci USA 75:1456,1978 13. Lebo RV, Carrano AV, Burkhart-Schultz K, Dozy AM, Yu LC, Kan YW: Assignment of human p-, y,and &globin genes to the short arm of chromosome 11 by chromosome sorting and DNA restriction enzyme analysis. Proc Natl Acad Sci USA 765804,1979 14. Scott AF, Phillips JA, Migeon BR: DNA restriction endonuclease analysis for localization of human p- and &globin genes on chromosome 11. Proc Natl Acad Sci USA 76:4563,1979 15. Sanders-Haigh L, Anderson WF, Franke U: The p-globin gene is on the short arm of human chromosome 11. Nature 283:683,1980 16. de Martinville B, Francke U: The c-Ha-ras 1, insulin and From www.bloodjournal.org by guest on June 16, 2017. For personal use only. HEMOGLOBIN A, p-globin loci map outside the deletion associated with aniridiaWilms' tumour. Nature 305:641,1983 17. Lebo RV, Chakravarti A, Buetow KH, Cheung M, Cann H, Cordell B, Goodman H: Recombination within and between the human insulin and p-globin gene loci. Proc Natl Acad Sci USA 804808,1983 18. Fearon ER, Antonarakis SE, Meyers DA, Levine M A c-Ha-ras-1 oncogene lies between p-globin and insulin loci on human chromosome l l p . Am J Hum Genet 36:329,1984 19. Antonarakis SE, Phillips JAI, Mallonee RL, Kazazian HH Jr, Fearon ER, Waber PG, Kronenberg HM, Ullrich A, Meyers D A p-Globin locus is linked to the parathyroid hormone (PTH) locus and lies between the insulin and PTH loci in man. Proc Natl Acad Sci USA 80:6615,1983 20. Flavell RA, Kooter JM, De Boer E, Little PFR, Williamson R: Analysis of the p-&globin gene loci in normal and Hb Lepore D N A Direct determination of gene linkage and intergene distance. Cell 15:25,1978 21. Mears JG, Ramirez F, Leibowitz D, Bank A: Organization of human 6- and p-globin genes in cellular DNA and the presence of intragenic inserts. Cell 15:15,1978 22. Bernards R, Kooter JM, Flavell RA: Physical mapping of the globin gene deletion in (Gp)"-thalassemia. Gene 6:265,1979 23. Forget BG: Structure and organization of the human globin genes. Tex Rep Biol Med 40:77,1980 24. Little PFR, Flavell RA, Kooter JM, Anison G, Williamson R: Structure of the human fetal globin gene locus. Nature 278:227, 1979 25. Fritsch EF, Lawn RM, Maniatis T: Molecular cloning and characterization of the human p-like globin gene cluster. Cell 19:959,1980 26. Shen S, Smithies 0: Human globin pseudop2 is not a globin related sequence. Nucleic Acids Res 107809,1982 27. Lawn RM, Fritsch EF, Parker RC, Blake G, Maniatis T: The isolation and characterization of linked 6- and P-globin genes from a cloned library of human DNA. Cell 15:1157,1978 28. Spritz RA, DeRiel JK, Forget BG, Weissman SM: Complete nucleotide sequence of the human &-globingene. Cell 21:639, 1980 29. Lawn RM, Efstratiadis A, O'Connell C, Maniatis T The nucleotide sequence of the human p-globin gene. Cell 21:647,1980 30. Slightom JL, Blechl AE, Smithies 0: Human fetal Gy and Ay globin genes: Complete nucleotide sequences suggest that DNA can be exchanged between these duplicated genes. Cell 21:627, 1980 31. Baralle FE, Shoulders CC, Proudfoot NJ: The primary structure of the human €-globin gene. Cell 21:621,1980 32. Czelusniak J, Goodman M, Hewett-Emmett D, Weiss ML, Venta PJ, Tashian RE: Phylogenetic origins and adaptive evolution of avian and mammalian haemoglobin genes. Nature 298:297,1982 33. Dayhoff MO, Hunt LT, MacLaughlin PJ, Jones DD: Atlas of Protein Sequence and Structure. Washington, DC, National Biomedical Foundation, 1972 34. Boyer SH, Crosby EF, Fuller GL, Noyes AN, Adams JG 111: The structure and biosynthesis of hemoglobins A and A, in the new world primate Ateles paniscus: A preliminary account. Ann NY Acad Sci 165:360,1969 35. Boyer SH, Crosby EF, Thurmon TF, Noyes AN, Fuller GF, Leslie SE, Shepard MK, Herndon CN: Hemoglobins A and A, in new world primates: Comparative variation and its evolutionary implications. Science 166:1428, 1969 36. Boyer SH, Crosby EF, Noyes AN, Fuller GF, Leslie SE, Donaldson LJ, Vrablik GR, Schaefer EW, Thurmon T F Primate hemoglobins: Some sequences and some proposals concerning the character of evolution and mutation. Biochem Genet 5:405,1971 2173 37. Boyer SH, Noyes AN, Timmons CF, Young RA: Primate hemoglobins: Polymorphisms and evolutionary patterns. J Hum Evol1:515,1972 38. Martin SL, Zimmer EA, Kan YW, Wilson AC: Silent &globin gene in Old World monkeys. Proc Natl Acad Sci USA 77:3563,1980 39. Martin SL, Vincent KA, Wilson AC: Rise and fall of the 6 globin gene. J Mol Biol 164513, 1983 40. Kimura A, Takagi Y: A frameshift addition causes silencing of the &globin gene in an Old World monkey, an anubis (Papio doguera). Nucleic Acids Res 11:2541,1983 41. Jeffreys AJ, Barrie PA, Harris S, Fawcett DH, Nugent W , Boyd AC: Isolation and sequence analysis of a hybrid &globin pseudogene from the brown lemur. J Mol Biol156:487,1982 42. Barrie PA, Jeffreys AJ, Scott AF: Evolution of the p-globin gene cluster in man and the primates. J Mol Biol149:319,1981 43. Efstratiadis A, Posakony JW, Maniatis T, Lawn RM, O'Connell C, Spritz RA, DeRiel JK, Forget BG, Weissman SM, Slightom JL, Blechl AE, Smithies 0, Baralle FE, Shoulders CC, Proudfoot NJ: The structure and evolution of the p-globin gene family. Cell 21:653, 1980 44. Koop BF, Siemieniak D, Slightom JL, Goodman M, Dunbar J, Wright PC, Simons EL: Tarsius 6- and p-globin genes: Conversions, evolution, and systematic implications. J Biol Chem 264:68, 1989 45. Spritz RA, Giebel LB: The structure and evolution of the spider monkey &globin gene. Mol Biol Evol5:21,1988 46. Hutchison CA, Hardies SC, Padgett RW, Weaver S, Edgell MH: The mouse globin pseudogene ph3 is descended from a premammalian &-globingene. J Biol Chem 259:12881, 1984 47. Hardison R C Comparison of the p-like globin gene families of rabbits and humans indicates that the gene cluster 5'-epsilon-y6-p-3' predates the mammalian radiation. Mol Biol Evol 1:390, 1984 48. Hardison RC, Margot JB: Rabbit globin pseudogene psi p2 is a hybrid of 6- and p-globin gene sequences. Mol Biol Evol1:302, 1984 49. Hardies SC, Edgell MH, Hutchison CA 111: Evolution of the mammalian p-globin gene cluster. J Biol Chem 259:3748, 1984 50. Tagle DA, Slightom JL, Jones RT, Goodman M: Concerted evolution led to high expression of a prosimian primate 6 globin gene locus. J Biol Chem 266:7469,1991 51. Petes TD: Evidence that structural variants within the human &globin protein may reflect genetic interactions between the 6- and p-globin genes. Am J Hum Genet 34:820,1982 52. A d a m JG 111, Morrison WT, Steinberg MH: Hb Parchman: A double crossover within a single human gene. Science 218:291, 1982 53. Rieder RF, Weatherall DJ: Studies of hemoglobin biosynthesis: Asynchronous synthesis of hemoglobin A and hemoglobin A,, by erythrocyte precursors. J Clin Invest 44:42,1965 54. Roberts AV, Weatherall DJ, Clegg JB: The synthesis of human haemoglobin A, during erythroid maturation. Biochem Biophys Res Commun 47231,1972 55. Wood WG, Old JM, Roberts AV, Clegg JB, Weatherall DJ: Human globin gene expression: Control of p, 6 and Sp chain production. Cell 15:437, 1978 56. Ross J, Pizarro A: Human p and 6 globin messenger RNAs turn over at different rates. J Mol Biol167:607,1983 57. Proudfoot NJ, Shander MHM, Manley JL, Gefter ML, Maniatis T: Structure and in vitro transcription of human globin genes. Science 209:1329,1980 58. Humphries RK, Ley T, Turner P, Moulton AD, Nienhuis From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2174 AW, Differences in human a-,8- and &-globingene expression in monkey kidney cells. Cell 30:173,1982 59. Grosveld GC, Rosenthal A, Flavell RA: Sequence requirements for the transcription of the rabbit p-globin gene in vivo: The -80 region. Nucleic Acids Res 10:4951,1982 60. Kosche K, Dobkin C, Bank A The role of intervening sequences (IVS) in human p globin gene expression. Blood 64:58a, 1984 (abstr, suppl) 61. Heller P, Yakulis V: The distribution of hemoglobin A2 Ann NY Acad Sci 16554,1968 62. Stamatoyannopoulos G: Human hemoglobin switching. Science 252:383,1991 63. de Bruin SH, Janssen LHM: Comparison of the oxygen and proton binding behavior of human hemoglobin A and A? Biochim Biophys Acta 295:490,1973 64. Eddison GG, Briehl RW, Ranney HM: Oxygen equilibria of hemoglobin A, and hemoglobin Lepore. J Clin Invest 43:2323,1964 65. Bunn HF, Briehl R W The interaction of 2,3-diphosphoglycerate with various human hemoglobins. J Clin Invest 49:1088,1970 66. Kinderlerer V, Lehmann H, Tipton KF: Thermal denaturation of human oxyhemoglobins A, A,, C, and S. Biochem J 135:805,1973 67. Nagel RL, Bookchin RM, Labie D, Wajcman H, IsaacSadeye WA, Honig GR: Structural basis for the inhibitory effects of hemoglobin F and hemoglobin A2 on the polymerization of hemoglobin S. Proc Natl Acad Sci USA 76:670,1979 68. Waye JS, Chui DHK, Eng B, Cai S, Coleman MB, Adams JG 111, Steinberg M H HbS/p"-thalassemia due to the approximately 1.4 kb deletion is associated with a relatively mild phenotype. Am J Hematoll991 (in press) 69. Klipstein FA, Ranney HM: Electrophoretic components of the hemoglobin of red cell membranes. J Clin Invest 39:1894,1960 70. Reiss GH, Ranney HM, Shaklai N: Association of hemoglobin C with erythrocyte ghosts. J Clin Invest 70:946,1982 71. Bunn HF, Forget BG: Hemoglobin: Molecular, Genetic and Clinical Aspects. Philadelphia, PA, Saunders, 1986 72. Gerald PS, Diamond L K The diagnosis of thalassemia trait by starch block electrophoresis. Blood 13:61, 1958 73. Baglioni C: The fusion of two peptide chains in hemoglobin Lepore and its intepretation as a genetic deletion. Proc Natl Acad Sci USA 48:1880,1962 74. Efremov GD: Hemoglobins Lepore and anti-Lepore. Hemoglobin 2:197, 1978 75. Ohta Y, Yamaoka K, Sumida I, Yanase T Haemoglobin Miyada, a p-S fusion peptide (anti-Lepore) type discovered in a Japanese family. Nature New Biol234:218,1971 76. Badr FM, Lorkin PA, Lehmann H: Hemoglobin P-Nilotic: Containing a p-S chain. Nature New Biol242:107, 1973 77. Abu-Sin A, Felice AE, Gravely ME, Wilson JB, Resse AL, Lam H, Miller A, Huismann THJ: Hb P Nilotic in association with p" thalassemia: cis-mutation of a hemoglobin pA chain regulatory determinant? J Lab Clin Med 93:973,1979 78. Roberts AV, Clegg JB, Weatherall DJ, Ohta Y: Synthesis in vitro of anti-Lepore haemoglobin. Nature New Biol245:23, 1973 79. Schriever HG, Leveckis DM: Quantitation of A, hemoglobin by polyacrylamide gel disc electrophoresis: a method with individual specimen standardization. Ann Clin Lab Sci 4:250, 1974 80. Williard RF, Love11WJ, Dreiling BJ, Steinberg MH: Electrophoresis of hemoglobin on polyacrylamide gels: Precise method for measurement of hemoglobin A2 Clin Chem 19:1082,1973 81. Neerhout RC, Kimmel JR, Wilson JF, Lahey ME: Quantitative determination of hemoglobin A, with the use of disc electrophoresis. J Lab Clin Med 67:314,1966 82. Marengo-Rowe AJ: Rapid electrophoresis and quantitation of hemoglobins on cellulose acetate. J Clin Pathol18:790,1965 STEINBERG AND ADAMS 83. Smithies 0: Zone electrophoresis in starch gels: Group variation in the serum proteins of normal human adults. Biochem J 61:629,1955 84. International Committee for Standardization in Haematology: Recommendations for selected methods for quantitative estimation of Hb A, and for Hb A2 reference preparation. Br J Haematol38:573,1978 85. White JM, Lewis SM: A report on the interlaboratory quantitation of haemoglobin A, and haemoglobin F. J Clin Pathol 26:864, 1973 86. Schmidt RM, Rucknagel DL, Necheles T F Comparison of methodologies for thalassemia screening by Hb A, quantitation. J Lab Clin Med 86:873,1975 87. Schmidt RM, Brosious EM: Quantitation of hemoglobin A? An interlaboratory study. Am J Clin Pathol71:534,1979 88. Rich SA, Ziegler FD, Grimley PM: An analysis of electrophoretic and microcolumn methods for the separation of hemoglobins A and A,. Clin Chim Acta 96:113,1979 89. Hoffman RS, Sprague CC, Hoffman L: Simple method for quantitation of A2 hemoglobin fraction. J Lab Clin Med 60504, 1962 90. Galanello R, Melis MA, Muroni P, Cao A Quantitation of Hb A, with DE-52 microchromatography in whole blood as screening test for p-thalassemia heterozygotes. Acta Haematol 57:32,1977 91. Schleider CT,Mayson SM, Huisman TH: Further modification of the microchromatographic determination of hemoglobin A,. Hemoglobin 1503,1977 92. Moors A, Melis-Liekens J, De Vlieger-Bensel M, De GroofCornelis E, Van Ros G: Evaluation of a simplified microchromatographic technique for hemoglobin A, determination. Acta Haemato1 61:15, 1979 93. Hamilton SR, Miller ME, Jessop M, Charache S: Comparison of microchromatography and electrophoresis with elution for hemoglobin A, (Hb A,) quantitation. Am J Clin Pathol 71:388, 1979 94. McCormack M K Quantitation of hemoglobin A, in a thalassemia trait by microcolumn chromatography. Clin Chim Acta 105:387,1980 95. Baine RM, Brown HG: Evaluation of a commercial kit for microchromatographic quantitation of hemoglobin A, in the presence of hemoglobin S. Clin Chem 27:1244,1981 96. Wrightstone RN, Huisman TH: On the levels of hemoglobins F and A, in sickle-cell anemia and some related disorders. Am J Clin Pathol61:375,1974 97. Morin LG: Improved batch and column separation in the assay of hemoglobin A? Clin Chem 22:2036,1976 98. Goldberg CAJ, Ross AC: Improved method for the determination of hemoglobin A, by starch-gel electrophoresis. Clin Chem 6:254, 1960 99. Turpeinen U: Liquid-chromatographic determination of hemoglobin A,. Clin Chem 32:999,1986 100. Gooding KM, Lu KC, Regnier FE: High-performance liquid chromatography of hemoglobins. I. Determination of hemoglobin A2 J Chromatogr 164506,1979 101. Wilson JB: Separation of human hemoglobin variants by HPLC, in Gooding K, Regmer F (eds): HPLC of Biological Macromolecules: Methods and Application. New York, NY,Dekker, 1989, p 1 102. Kutlar F, Kutlar A, Huisman TH: Separation of normal and abnormal hemoglobin chains by reversed-phase high-performance liquid chromatography. J Chromatogr 357:147,1986 103. Schroeder WA, Shelton JB, Shefton JR, Huynh V: The estimation of Hb A, in the presence of Hb C or Hb E by reverse From www.bloodjournal.org by guest on June 16, 2017. For personal use only. HEMOGLOBIN A, phase high performance liquid chromatography. Hemoglobin 10: 253,1986 104. Shelton JB, Shelton JR, Schroeder W A Separation of globin chains on a large pore C, column. J Liq Chromatogr 1:1969, 1984 105. Suhrland LG, Armentrout SA, Daniel TM: Immunoassay of hemoglobin A,. J Lab Clin Med 71:1021,1968 106. Gamer FA, Jones CS, Baker MM, Altay G, Barton BP, Gravely M, Huisman TH: Specific radioimmunochemical identification and quantitation of hemoglobins A, and F. Am J Hematol 1:459, 1976 107. Gamer FA, Singh H, Moscoso H, Kestler DP, McGuire BS Jr: Identification and quantification of hemoglobins A, and Barts with an enzyme-labeled immunosorbent assay. Clin Chem 30:1205, 1984 108. Heller P, Yakulis V, Josephson AM: Antigenicity of A, hemoglobin. Nature 189:495,1961 109. Felicetti L, Novelletto A, Benincasa A, Terrenato L, Colombo B: The HbA/HbA, ratio in newborns and its correlation with fetal maturity. Br J Haematol56:465,1984 110. Neumeyer P, Betke K Haemoglobin A, in newborn infants of different maturity. Eur J Pediatr 146598,1987 111. Serjeant BE, Mason KP, Serjeant GR: The development of haemoglobin A, in normal negro infants and in sickle cell disease. Br J Haematol39:259,1978 112. Huehns ER, Shooter EM: The polypeptide chains of haemoglobin-A,2 and Haemoglobin-G2. J Mol Biol3:257, 1961 113. Tegos C, Beutler E Glycosylated hemoglobin A, components. Blood 56571, 1980 114. Bisse E, Abraham A, Stallings M, Perry RE, Abraham EC: High-performance liquid chromatographic separation and quantitation of glycosylated hemoglobin Az as an alternate index of glycemic control. J Chromatogr 374:259,1986 115. Bunn HF: Subunit assembly of hemoglobin: An important determinant of hematologic phenotype. Blood 69:1,1987 116. Mrabet NT, McDonald MJ, Turci S, Sarkar R, Szabo A, Bunn HF: Electrostatic attraction governs the dimer assembly of human hemoglobin. J Biol Chem 2615222,1986 117. McDonald MJ, Turci SM, Mrabet NT, Himelstein BP, Bunn H F The kinetics of assembly of normal and variant human oxyhemoglobins. J Biol Chem 2625951,1987 118. Ochoa S: Regulation of protein synthesis initiation in eucaryotes. Arch Biochem Biophys 223:325,1983 119. Alperin JB, Dow PA, Petteway MB: Hemoglobin Az levels in health and various hematologic disorders. Am J Clin Pathol 67:219, 1977 120. Rai R, Pati H, Sehgal AK, Sundaram KR, Saraya AK: Hemoglobin A, in iron deficiency and megaloblastic anemia: Relation with severity and etiology of anemia. Indian Pediatr 24:301,1987 121. Ali MA, Schwertner E: Hemoglobin Az level. A proposed test for confirming the diagnosis of iron deficiency. Am J Clin Pathol63:549,1975 122. Wasi P, Disthasongchan P, Na-Nakorn S: The effect of iron deficiency on the levels of hemoglobin A, and E. J Lab Clin Med 71:85,1968 123. Galanello R, Ruggeri R, Addis M, Paglietti E, Cao A Hemoglobin A, in iron deficient P-thalassemia heterozygotes. Hemoglobin 5:613, 1981 124. White JM, Brain MC, Ali MAM: Globin synthesis in sideroblastic anaemia. I a and P peptide chain synthesis. Br J Haematol20:263,1971 125. Feuilhade F, Testa U, Vainchenker W, Henri A, That HT, Beuzard Y, Galacteros F, Dreyfus B, Rochant H: Comparative patterns of i-antigen expression, F-cell frequency and Hb A, level 2175 in acute myeloid leukemia and in acute lymphoid leukemia. Leuk Res 5:203,1981 126. Sheridan BL, Weatherall DJ, Clegg JB, Pritchard J, Wood WG, Callander ST, Durant IJ, McWhinter WR, Ali M, Partridge W, Thompson E N The pattern of foetal haemoglobin production in leukaemia. Br J Haematol32487,1976 127. Dover GJ,Boyer SH, Zinkham WH, Kazazian HH Jr, Pinney DJ, Sigler A Changing erythrocyte populations in juvenile chronic myelocytic leukemia: Evidence for disordered regulation. Blood 49:355,1977 128. Weatherall DJ, Edwards JA, Donohue W T A Haemoglobin and red cell enzyme changes in juvenile chronic myeloid leukemia. Br Med J 1:679,1968 129. Aksoy M, Erdem S: Decrease in the concentration of haemoglobin A, during erythroleukaemia. Nature 213522,1967 130. Markham RE, Butler F, Goh K, Rowley P T Erythroleukemia manifesting GP-thalassemia. Hemoglobin 771,1983 131. Weatherall DJ, Clegg JB: The Thalassaemia Syndromes. New York, NY,Blackwell, 1981 132. Kutlar F, Gonzalez-Redondo JM, Kutlar A, Gurgey A, Altay C, Efremov GD, Kleman K, Huisman TH: The levels of c,y, and 6 chains in patients with Hb H disease. Hum Genet 82:179, 1989 133. Fessas P, Stamatoyannopoulos G: Absence of haemoglobin Az in an adult. Nature 1215,1962 134. Moi P, Paglietti E, Sanna A, Brancati C, Tagarelli A, Galanello R, Cao A, Pirastu M: Delineation of the molecular basis of 6- and normal HbA, p-thalassemia. Blood 72530,1988 135. Losekoot M, Fodde R, Giordano PC, Bernini L F A novel 6 zero-thalassemia arising from a frameshift insertion, detected by direct sequencing of enzymatically amplified DNA. Hum Genet 83:75,1989 136. Nakamura T, Takihara Y, Ohta Y, Fujita S, Takagi Y, Fukumaki Y: A &globin gene derived from patients with homozygous 6 "-thalassemia functions normally on transient expression in heterologous cells. Blood 70:809, 1987 137. Loudianos G, Cao A, Pirastu M, Vassilopoulos G, Kollia P, Loukopoulos D: Molecular basis of the 6 thalassemia in cis to hemoglobin Knossos variant. Blood 77:2087,1991 137a. Olds RJ, Sura T, Jackson B, Wonke B, Hoffbrand AV, Thein S L A novel 6' mutation in cis with Hb Knossos: A study of different genetic interactions in three Egyptian families. Br J Haematol78:430, 1991 138. Kulozik AE, Yawood N, Jones RW: The Corfu 6 p zero thalassemia: A small deletion acts at a distance to selectively abolish P globin gene expression. Blood 71:457,1988 139. Galanello R, Melis MA, Podda A, Monne M, Perseu L, Loudianos G, Cao A, Pirastu M, Piga A: Deletion &thalassemia: The 7.2 kb deletion of Corfu GP-thalassemia in a non-pthalassemia chromosome. Blood 75:1747,1990 140. Horton B, Payne RA, Bridges MT, Huisman THJ: Studies on an abnormal minor hemoglobin component (Hb-B2). Clin Chim Acta 6:246,1961 141. Huisman THJ,Horton B, Sebens TB: Hematology identity of the a-chains of the minor human haemoglobin components A, and A; with the a-chains of human haemoglobin A and F. Nature 190:357,1961 142. Lyons DJ, Gilvarry JM, Fielding J F Severe haemolysis associated with hepatitis A and normal glucose-6-phosphate dehydrogenase status. Gut 31:838,1990 143. Hatton CSR, Wilkie AOM, Drysdale HC, Wood WG, Vickers MA, Sharpe J, Ayyub H, Pretorius IM, Buckle VJ, Higgs DR: a-Thalassemia caused by a large (62 kb) deletion upstream of the human a globin gene cluster. Blood 76:221, 1990 144. Codrington JF, Li H-W, Kutlar F, Gu L-H, Ramachandran From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2176 M, Huisman THJ: Observations on the levels of Hb A, in patients with different p-thalassemia mutations and a 6 chain variant. Blood 76:1246,1990 145. Jankovic L, Efremov GD, Petkov G, Kattamis C, George E, Yang KG, Stoming TA, Huisman TH: Two novel polyadenylation mutations leading to p +-thalassemia.Br J Haematol75:122, 1990 146. Kutlar A, Kutlar F, Gu LG, Mayson SM, Huisman THJ: Fetal hemoglobin in normal adults and p-thalassemia heterozygotes. Hum Genet 85:106,1990 147. Gonzalez-Redondo JM, Stoming TA, Kutlar A, Lanclos KD, Howard EF, Fei YJ, Aksoy M, Altay C, Gurgey A, Basak AN, Efremov GD, Petkov G, Huisman THJ: A C + T substitution at nt -101 in a conserved DNA sequence of the promoter region of the P-globin gene is associated with “silent P-thalassemia.” Blood 73:1705,1989 148. Loukopoulos D, Fessas P: The distribution of hemoglobin types in thalassemic erythrocytes. J Clin Invest 44:231, 1965 149. Cech P, Testa U, Dubart A, Schneider P, Bachmann F, Guerrasio A, Beuzard Y, Schmidt PM, Clement F, Rosa J: Lasting Hb F reactivation and Hb A, reduction induced by the treatment of Hodgkin’s disease in a woman heterozygous for p-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F. Acta Haematol67:275,1982 150. Krishnamoorthy R, Elion J, Kuhn JM, Lagrange JL, Rochette J, Luton JP, Bricaire H, Labie D: Haemoglobin A, is elevated in hyperthyroid patients. Nouv Rev Fr Hematol24:39,1982 151. Lee RC, Huisman THJ: Study of a family possessing hemoglobin C. Classical thalassemia and the abnormal minor hemoglobin component A;. Am J Hum Genet 15:69,1963 152. Steinberg MH, Coleman MB, Adams JG 111: P-Thalassemia with exceptionally high hemoglobin A,. Differential expression of the 6-lgobin gene in the presence of p-thalassemia. J Lab Clin Med 100:548,1982 153. Gonzalez-Redondo JM, Kattamis C, Huisman THJ:Characterization of three types of p “-thalassemia resulting from a partial deletion of the p-globin gene. Hemoglobin 13:377,1989 154. Orkin SH, Old JM, Weatherall DJ, Nathan DG: Partial deletion of p-globin gene DNA in certain patients with Po thalassemia. Proc Natl Acad Sci USA 76:2400,1979 155. Sanguansermsri T, Pape M, Laig M, Hundrieser J, Flatz G: pG-Thalassemia in a Thai family is caused by a 3.4 kb deletion including the entire p-globin gene. Hemoglobin 14:157,1990 156. Tsai SF, Martin DI, Zon LI, D’Andrea AD, Wong GG, Orkin SH: Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells. Nature 339:446,1989 157. Townes TM, Behringer RR: Human globin locus activation region (LAR): Role in temporal control. Trends Genet 6:219,1990 158. Orkin SH: Globin gene regulation and switching: Circa 1990. Cell 63:665, 1990 159. Dillon N, Grosveld F: Human y-globin genes silenced independently of other genes in the p-globin locus. Nature 350:252, 1991 160. Ohi S, Dixit M, Tillery MK, Plonk SG: Construction and replication of an adeno-associated virus expression vector that contains human p-globin cDNA. Gene 89:279,1990 161. Schroeder WA, Huisman THJ, Hyman C, Shelton JR, Apell G: An individual with “Miyada”-like hemoglobin indistinguishable from hemoglobin A,. Biochem Genet 10:135,1975 162. Steinberg MH, Coleman MB, Adams JG 111, Waye JS, Chui DHK: High hemoglobin A, @-thalassemia.J Lab Clin Med 1991 (in press) 163. Embury SH, Dozy AM, Miller J, Davis JR Jr, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer STEINBERG AND ADAMS WC: Concurrent sickle-cell anemia and a-thalassemia: Effect on severity of anemia. N Engl J Med 306:270,1982 164. Higgs DR, Aldridge BE, Lamb J, Clegg JB, Weatherall DJ, Hayes RJ, Grandison Y, Lowrie Y, Mason KP, Serjeant BE, Serjeant GR: The interaction of wthalassemia and homozygous sickle-cell disease. N Engl J Med 306:1441, 1982 165. Steinberg MH, Rosenstock W, Coleman MB, A d a m JG 111, Platica 0, Cedeno M, Reider RF, Wilson JT, Milner P, West S: Effects of thalassemia and microcytosis upon the hematological and vaso-occlusive severity of sickle cell anemia. Blood 63: 1353, 1984 166. Francina A, Dorleac E, Baudonnet C, Jaccoud P, Delaunay J: Microchromatofocusing of hemoglobins. Increased hemoglobin A, percentage in sickle cell trait. Clin Chim Acta 121:261, 1982 167. Whitten WJ, Rucknagel D L The proportion of Hb A, is higher in sickle cell trait than in normal homozygotes. Hemoglobin 5:371, 1981 168. Kendall AG, Bastomsky CH: Hemoglobin A, in hyperthyroidism. Hemoglobin 5:571, 1981 169. Kuhn JM, Rieu M, Rochette J, Krishnamoorthy R, Labie D, Elion J, Luton JP, Bricaire H: Influence of thyroid status on hemoglobin A, expression. J Clin Endocrinol Metab 57:344, 1983 170. Henshaw LA, Tizzard JL, Booth K, Beard ME: Haemoglobin A, levels in vitamin B12 and folate deficiency. J Clin Pathol 31:960, 1978 171. Bradley TB, Ranney HM: Acquired disorders of haemoglobin. Prog Haematol8:77,1973 172. Rieder RF, Zinkham WH, Holtzman NA: Haemoglobin Zurich: Clinical, chemical and kinetic studies. Am J Med 39:4,1965 173. Arends T: High concentrations of haemoglobin A, in malaria patients. Nature 215:1517, 1967 174. Lie-Injo LE, Lopez CG, Lopez M: Hemoglobin A, in malaria patients. Trans R SOCTrop Med Hyg 65:480,1971 175. Wasi P, Kruatrachue M, Piankijagum A, Pravatmeung P: Hemoglobin A, and E levels in malaria. J Med Assoc Thailand 54:559,1971 176. Van Ros G, Moors A, De Vlieger M, De Groof E: Hemoglobin A, levels in malaria patients. Am J Trop Med Hyg 27:659,1978 177. Esan GJF, Bienzle U, Miller G, Adesina TAO: Hemoglobin A, and malaria. Am J Trop Med Hyg 22153,1973 178. Harmeling JG, Moquin RB: An abnormal elevation of hemoglobin A, in hereditary spherocytosis. Am J Clin Pathol 47:454, 1967 179. Waye JS, Cai S-P, Eng B, Clark C, Adams JG 111, Chui DHK, Steinberg MH: High hemoglobin A, Po-thalassemia due to a 532-basepair deletion of the 5’ p-globin gene region. Blood 77:1100,1991 180. Padanilam BJ, Felice AE, Huisman THJ: Partial deletion of the 5‘ 0-globin gene region causes po-thalassemia in members of an American black family. Blood 64:941, 1984 181. Diaz-Chico JC, Yang KG, Kutlar A, Reese AL, Aksoy M, Huisman THJ: An -300 bp deletion involving part of the 5’ p-globin gene region is observed in members of a Turkish family with p-thalassemia. Blood 70:583,1987 182. Popovich BA, Rosenblatt DS, Kendall AG, Nishioka Y: Molecular characterization of an atypical p-thalassemia caused by a large deletion in the 5’ p-globin gene region. Am J Hum Genet 39:797, 1986 183. Gilman JB: The 12.6 kilobase deletion in a Dutch Pothalassemia. Br J Haematol76:369,1987 184. Harano T, Harano K, Kushida Y, Ueda S, Kawakami H: Hb A, Niigata [Sl(NAl) Val + Ala]: A new S chain variant found in Japanese. Hemoglobin 15:335,1991 185. Jones RT, Brimhall B, Huehns ER, Barnicot N A Hemoglo- From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 2177 HEMOGLOBIN A, bin Sphakia: A 6 chain variant of hemoglobin A, from Crete. Science 151:1406, 1966 186. Ranney HM, Jacobs AS, Udem L, Zalusky R: Hemoglobin NYU, a 6 chain variant, a,6, 12 lys. J Clin Invest 48:2057,1969 187. Rieder RF, Clegg JB, Weiss HJ, Chiristy NP, Rabinowitz R: Hemoglobin A,-Roosevelt: a2P220 Val + Glu. Biochim Biophys Acta 439501,1979 188. Jones RT, Brimhall B: Structural characterization of two 6 chain variants. J Biol Chem 2425141,1967 189. Brennan SO, Williamson D, Smith MB, Cauchi MN, Macphee A, Carrell RW: HbA, Victoria 6 24 (B6) Gly + Asp. A new 6 chain variant occurring with P-thalassemia. Hemoglobin 8:163, 1984 190. Ohba Y, Igarashi M, Tsukahara M, Nakashima M, Sanada C, Ami M, Arai Y, Miyaji T: Hb A, Yokoshima a28,25 (B7) Gly+Asp. A new 6 chain variant found in a Japanese family. Hemoglobin 9613, 1985 191. Sharma RS, Harding DL, Wong SC, Wilson JB, Gravely ME, Huisman THJ: A new chain variant, haemoglobin A2Melbourne or a26,43 Glu + Lys (CD2). Biochim Biophys Acta 359:233,1974 192. Leung H, Gilbert AT, Fleming PJ, Wong J, Hughes WG, Hussein S, Nash AR: Hb A, Parkville or 647 (CD6) Asp + Val: A new 6 chain variant. Hemoglobin 1991 (in press) 193. Alberti R, Tentori L, Marinucci M, Borghesi V: Hb A,-Adria (651 Pro Arg (D2)): A new &chain variant found in association with P-thalassemia. Hemoglobin 2:171,1978 194. Lie-Injo LE, Pribada W, Boerma FW, Efremov GD, Wilson JB, Reynolds CA, Huisman THJ: Hemoglobin A,-Indonesia or a,6, 69 (E13) Gly + Arg. Biochim Biophys Acta 393:379,1971 195. Lie-Injo LE, Poey-Oey HG, Mossberger RJ: Haptoglobins, transferrins, and hemoglobin A, in Indonesians. Am J Hum Genet 20:470, 1968 196. Fujita S, Ohta Y, Saito S, Kobayashi Y, Naritomi Y, - Kawaguchi T, Imamura T, Wada Y, Hayashi A: Hemoglobin A, 90 (F6) Glu + Val): A new 6 chain variant. HemogloHonai (~1~6, bin 9597,1985 197. Codrington JF, Kutlar F, Harris HF, Wilson JB, Stoming TA, Huisman THJ: Hb A,-Wrens or aZ6,98 (FG5) Val + Met, an unstable 6 chain variant identified by sequence analysis of amplified DNA. Biochim Biophys Acta 1009:87,1989 198. Salkie ML, Gordon PA, Riga1 WM, Lam H, Wilson JB, Headlee ME, Huisman TH: Hb A,-Canada or a,&,99 (Gl) Asp replaced by Asn, a newly discovered 6 chain variant with increased oxygen affinity occurring in cis to P-thalassemia. Hemoglobin 6:223,1982 199. Sharma RS, Williams L, Wilson JB, Huisman THJ: Hemoglobin-A,-Coburg or a28,116 Arg + His (G18). Biochim Biophys Acta 393:379,1975 200. Romero-Garcia C, Navarro JL, Lam H, Webber BB, Haedlee MG, Wilson JB, Huisman THJ: Hb A,-Manzanares or a,6,121 (GH4) Glu + Val, an unstable 6 chain variant observed in a Spanish family. Hemoglobin 7:435,1983 201. Juricic D, Crepinko I, Efremov GD, Lam H, Webber BB, Headlee MG, Huisman THJ: Hb A,-Zagreb or a&, 125 (H3) Gln +Glu, a new 6 chain variant in association with SPthalassemia. Hemoglobin 7:443, 1983 202. De Jong WWW, Bernini LF: Hemoglobin Babinga (6136 glycine + aspartic acid): A new 6 chain variant. Nature 219:1360, 1968 203. Williamson D, Brennan SO, Stroberg H, Whitty J, Carrell RW: Hemoglobin A, Fitzroy 6142 Ala + Asp: A new &chain variant. Hemoglobin 8:325, 1984 204. Loudianos G , Murru S, Kanavakis E, Metaxotou-Mavromati A, Theodoropoulou D, Kattamis C, Cao A, Pirastu M: A new 6 chain variant hemoglobin A,-Corfu or a$, 116 Arg Cys ((318) detected by &globin gene analysis in a Greek family. Hum Genet 87:237, 1991 - From www.bloodjournal.org by guest on June 16, 2017. For personal use only. 1991 78: 2165-2177 Hemoglobin A2: origin, evolution, and aftermath MH Steinberg and JG 3d Adams Updated information and services can be found at: http://www.bloodjournal.org/content/78/9/2165.citation.full.html Articles on similar topics can be found in the following Blood collections Information about reproducing this article in parts or in its entirety may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#repub_requests Information about ordering reprints may be found online at: http://www.bloodjournal.org/site/misc/rights.xhtml#reprints Information about subscriptions and ASH membership may be found online at: http://www.bloodjournal.org/site/subscriptions/index.xhtml Blood (print ISSN 0006-4971, online ISSN 1528-0020), is published weekly by the American Society of Hematology, 2021 L St, NW, Suite 900, Washington DC 20036. Copyright 2011 by The American Society of Hematology; all rights reserved.